Pharma companies becoming more aggressive towards generics firms

News and Analysis

Published: 01 August 2006

Volume 5, pages 619–620, (2006)

Cite this article

Merck's tactics with statin shows how brand companies are upping the ante to retain market share

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Authors

Simon Frantz
View author publications
You can also search for this author in PubMed Google Scholar

Frantz, S. Pharma companies becoming more aggressive towards generics firms. Nat Rev Drug Discov 5, 619–620 (2006). https://doi.org/10.1038/nrd2121

Generika in Österreich 2003–2008: ein Update
- Markus Müller
Wiener klinische Wochenschrift (2008)

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.